NIVOLUMAB-INDUCED MYASTHENIA GRAVIS WITH MYOCARDITIS AND MYOSITIS

被引：0
|
作者：
Tamkus, Greta
Boucekkine, Houda
Seibert, Katherine
Eng, Kevin
Betancourt, Jaime
机构：
来源：
CHEST | 2023年 / 164卷 / 04期
关键词：
D O I：
10.1016/j.chest.2023.07.2779
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
引用
收藏
页码：4268A / 4269A
页数：2
相关论文
共 50 条
  • [31] Coexisting of myasthenia gravis and fulminant myocarditis induced by nivolumab in a patient with ureteral epithelial cancer
    Zhang, Jing
    Li, Jiayin
    Zhai, Linzhu
    Lin, Lizhu
    NEUROENDOCRINOLOGY LETTERS, 2021, 42 (06) : 383 - 386
  • [32] Nivolumab-induced myositis: A case report and a literature review
    Bourgeois-Vionnet, Julie
    Joubert, Bastien
    Bernard, Emilien
    Sia, Marie Angele
    Pante, Vanessa
    Fabien, Nicole
    Honnorat, Jerome
    Streichenberger, Nathalie
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2018, 387 : 51 - 53
  • [33] Clinical characteristics, diagnosis and management of nivolumab-induced myocarditis
    Li, Meng-Ting
    He, Yang
    Huang, Si-Yong
    Hu, Xiao
    Chen, Ji-Sheng
    INVESTIGATIONAL NEW DRUGS, 2024, 42 (01) : 116 - 126
  • [34] A BROKEN HEART: A CASE OF IPILIMUMAB AND NIVOLUMAB-INDUCED MYOCARDITIS
    Chacon, Daniel
    Heydari-Kamjani, Milad
    Cragnotti, Giovanni
    Pendlebury, David
    Conley, Sean
    Sonnino, Alice
    Placido, Jenny
    Koppikar, Maekhila
    CHEST, 2024, 166 (04) : 309A - 310A
  • [35] Clinical characteristics, diagnosis and management of nivolumab-induced myocarditis
    Meng-Ting Li
    Yang He
    Si-Yong Huang
    Xiao Hu
    Ji-Sheng Chen
    Investigational New Drugs, 2024, 42 : 116 - 126
  • [36] Nivolumab/pegaldesleukinDe novo myasthenia gravis and myositis: 2 case reports
    Reactions Weekly, 2020, 1808 (1) : 231 - 231
  • [37] PEMBROLIZUMAB-INDUCED TRIPLE-M (MYOCARDITIS-MYOSITIS-MYASTHENIA GRAVIS) SYNDROME
    Onkaramurthy, Neema Jayachamarajapura
    Kumar, Sany
    Pastores, Stephen
    CRITICAL CARE MEDICINE, 2024, 52
  • [38] Immunotherapy-Induced Overlap Syndrome: Myositis, Myasthenia Gravis, and Myocarditis-A Case Series
    Aggarwal, Nikhil
    Bianchini, Diletta
    Parkar, Rosemeen
    Turner, Jennifer
    CASE REPORTS IN MEDICINE, 2024, 2024
  • [39] Fatal triad of checkpoint inhibitors: Pembrolizumab induced myasthenia gravis with myositis and myocarditis in a patient with thymoma
    Seker, Demet
    Yildirim, Ahmet
    NEUROLOGY ASIA, 2023, 28 (02) : 439 - 443
  • [40] CONCURRENT MYASTHENIA GRAVIS, MYOCARDITIS, AND MYOSITIS SECONDARY TO IMMUNE CHECKPOINT INHIBITORS
    Rode, Shomita
    Reed, Mark
    Parker, William A.
    Johnson, Jeremy C.
    Kalanjeri, Satish
    CHEST, 2024, 166 (04) : 2693A - 2694A
12345